Clinical Trials List
2016-05-01 - 2018-12-14
Phase III
Terminated3
ICD-10F20
Schizophrenia
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
The Actual Total Number of Participants Enrolled
0 Completed
Taiwan National PI
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
9 Completed
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
17 participants
-
Global
300 participants
